These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21821829)

  • 1. Valid relevance in medical practice: the inadequacy of the linear model of health and disease: the Weisenfeld lecture.
    Spaeth GL
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6250-6. PubMed ID: 21821829
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture.
    Brubaker RF
    Am J Ophthalmol; 1996 May; 121(5):473-83. PubMed ID: 8610790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring rates of structural and functional change in glaucoma.
    Nouri-Mahdavi K; Caprioli J
    Br J Ophthalmol; 2015 Jul; 99(7):893-8. PubMed ID: 25287369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rationale for lowering intraocular pressure in glaucoma.
    Weinreb RN
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S335-6. PubMed ID: 11434935
    [No Abstract]   [Full Text] [Related]  

  • 5. Scanning laser polarimetry and progression of visual field defects after intraocular pressure increase.
    Lopes JF; Susanna R
    Arch Ophthalmol; 2003 Oct; 121(10):1500-1. PubMed ID: 14557197
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanistic insights into glaucoma provided by experimental genetics the cogan lecture.
    John SW
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2649-61. PubMed ID: 16043833
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflections on "hot" blind spots: lessons from research on aging macula disorder and glaucoma: the Weisenfeld lecture.
    de Jong PT
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7717-24, 7716. PubMed ID: 21960644
    [No Abstract]   [Full Text] [Related]  

  • 8. Can Visual Field Progression be Predicted by Confocal Scanning Laser Ophthalmoscopic Imaging of the Optic Nerve Head in Glaucoma? (An American Ophthalmological Society Thesis).
    Danias J; Serle J
    Trans Am Ophthalmol Soc; 2015; 113():T4. PubMed ID: 26549913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationships between spectral-domain OCT and standard achromatic perimetry.
    Nilforushan N; Nassiri N; Moghimi S; Law SK; Giaconi J; Coleman AL; Caprioli J; Nouri-Mahdavi K
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2740-8. PubMed ID: 22447869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 11. Associating the magnitude of relative afferent pupillary defect (RAPD) with visual field indices in glaucoma patients.
    Schiefer U; Dietzsch J; Dietz K; Wilhelm B; Bruckmann A; Wilhelm H; Kitiratschky V; Januschowski K
    Br J Ophthalmol; 2012 May; 96(5):629-33. PubMed ID: 22328816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographic relationship between frequency-doubling technology threshold values.
    Fuertes-Lazaro I; Sanchez-Cano A; Ferreras A; Larrosa JM; Garcia-Martin E; Pablo LE
    Acta Ophthalmol; 2012 Mar; 90(2):e144-50. PubMed ID: 22103468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.
    Schwartz M
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1407-11. PubMed ID: 12657572
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor Lecture.
    Bito LZ
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1126-33. PubMed ID: 11328718
    [No Abstract]   [Full Text] [Related]  

  • 17. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationship and diagnostic value of RNFL Area Index compared with circumpapillary RNFL thickness by spectral-domain OCT.
    Park HY; Park CK
    J Glaucoma; 2013 Feb; 22(2):88-97. PubMed ID: 23232911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal structure-function relationships with scanning laser ophthalmoscopy and standard achromatic perimetry.
    Nassiri N; Nilforushan N; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
    Arch Ophthalmol; 2012 Jul; 130(7):826-32. PubMed ID: 22776919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsar perimetry in the diagnosis of early glaucoma.
    Gonzalez de la Rosa M
    Am J Ophthalmol; 2011 Sep; 152(3):500-501. PubMed ID: 21855674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.